Adolescence is a developmental period that has been associated with heightened sensitivity to psychostimulant-induced reward, thus placing adolescents at increased risk to develop drug addiction. Although alterations in dopamine-induced synaptic plasticity are perhaps the most critical factor in mediating addiction processes, developmental differences in the cell signaling mechanisms that contribute to synaptic plasticity, and their contribution to adolescent reward sensitivity, has been grossly understudied. The most abundant dopamine receptors, the D1 and D2 receptors, as well as the dopamine D1-D2 receptor heteromer, exhibit age-dependent and brain region-specific changes in their expression and function and are responsible for regulating cell signaling pathways known to significantly contribute to the neurobiological mechanisms underlying addiction. The D1-D2 receptor heteromer, for instance, has been associated with calcium calmodulin kinase IIα, brain-derived neurotrophic factor and glycogen synthase kinase 3 (GSK-3) signaling, three proteins highly implicated in the regulation of glutamate transmission and synaptic plasticity and which regulate addiction to amphetamine, opioids and cocaine. Therefore, in this review the importance of these signaling proteins as potential mediators of addiction susceptibility in adolescence will be highlighted, and the therapeutic potential of the D1-D2 receptor heteromer in addiction will be discussed. It is the overall goal of this review to draw attention to the research gap in dopamine-induced cell signaling in the adolescent brain - knowledge that would provide much-needed insights into adolescent addiction vulnerability.

Keywords:
Adolescence, Addiction, Calcium calmodulin kinase II, Brain-derived neurotrophic factor, Glycogen synthase kinase 3, Dopamine D1-D2 receptor heteromer
1.
Chambers RA, Taylor JR, Potenza MN: Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability. Am J Psychiatry 2003;160:1041-1052.
2.
Sturman DA, Moghaddam B: The neurobiology of adolescence: changes in brain architecture, functional dynamics, and behavioral tendencies. Neurosci Biobehav Rev 2011;35:1704-1712.
3.
Andersen SL: Trajectories of brain development: point of vulnerability or window of opportunity? Neurosci Biobehav Rev 2003;27:3-18.
4.
Laviola G, Adriani W, Terranova ML, Gerra G: Psychobiological risk factors for vulnerability to psychostimulants in human adolescents and animal models. Neurosci Biobehav Rev 1999;23:993-1010.
5.
Costello EJ, Mustillo S, Erkanli A, Keeler G, Angold A: Prevalence and development of psychiatric disorders in childhood and adolescence. Arch Gen Psychiatry 2003;60:837-844.
6.
Patton GC, Viner R: Pubertal transitions in health. Lancet 2007;369:1130-1139.
7.
Anker JJ, Carroll ME: Reinstatement of cocaine seeking induced by drugs, cues, and stress in adolescent and adult rats. Psychopharmacology (Berl) 2010;208:211-222.
8.
Shahbazi M, Moffett AM, Williams BF, Frantz KJ: Age- and sex-dependent amphetamine self-administration in rats. Psychopharmacology (Berl) 2008;196:71-81.
9.
Zakharova E, Leoni G, Kichko I, Izenwasser S: Differential effects of methamphetamine and cocaine on conditioned place preference and locomotor activity in adult and adolescent male rats. Behav Brain Res 2009;198:45-50.
10.
Zakharova E, Wade D, Izenwasser S: Sensitivity to cocaine conditioned reward depends on sex and age. Pharmacol Biochem Behav 2009;92:131-134.
11.
Brenhouse HC, Andersen SL: Delayed extinction and stronger reinstatement of cocaine-conditioned place preference in adolescent rats, compared to adults. Behav Neurosci 2008;122:460-465.
12.
Badanich KA, Adler KJ, Kirstein CL: Adolescents differ from adults in cocaine-conditioned place preference and cocaine-induced dopamine in the nucleus accumbens septi. Eur J Pharmacol 2006;550:95-106.
13.
Wong WC, Ford KA, Pagels NE, McCutcheon JE, Marinelli M: Adolescents are more vulnerable to cocaine addiction: behavioral and electrophysiological evidence. J Neurosci 2013;33:4913-4922.
14.
Selemon LD: A role for synaptic plasticity in the adolescent development of executive function. Transl Psychiatry 2013;3:e238.
15.
Cass DK, Thomases DR, Caballero A, Tseng KY: Developmental disruption of γ-aminobutyric acid function in the medial prefrontal cortex by noncontingent cocaine exposure during early adolescence. Biol Psychiatry 2013;74:490-501.
16.
Sturman DA, Moghaddam B: Reduced neuronal inhibition and coordination of adolescent prefrontal cortex during motivated behavior. J Neurosci 2011;31:1471-1478.
17.
Sturman DA, Moghaddam B: Striatum processes reward differently in adolescents versus adults. Proc Natl Acad Sci USA 2012;109:1719-1724.
18.
McCutcheon JE, Conrad KL, Carr SB, Ford KA, McGehee DS, Marinelli M: Dopamine neurons in the ventral tegmental area fire faster in adolescent rats than in adults. J Neurophysiol 2012;108:1620-1630.
19.
Brenhouse HC, Sonntag KC, Andersen SL: Transient D1 dopamine receptor expression on prefrontal cortex projection neurons: relationship to enhanced motivational salience of drug cues in adolescence. J Neurosci 2008;28:2375-2382.
20.
Andersen SL, Thompson AT, Rutstein M, Hostetter JC, Teicher MH: Dopamine receptor pruning in prefrontal cortex during the periadolescent period in rats. Synapse 2000;37:167-169.
21.
Teicher MH, Andersen SL, Hostetter JC Jr: Evidence for dopamine receptor pruning between adolescence and adulthood in striatum but not nucleus accumbens. Brain Res Dev Brain Res 1995;89:167-172.
22.
Tarazi FI, Baldessarini RJ: Comparative postnatal development of dopamine D1, D2 and D4 receptors in rat forebrain. Int J Dev Neurosci 2000;18:29-37.
23.
Hasbi A, Fan T, Alijaniaram M, Nguyen T, Perreault ML, O'Dowd BF, George SR: Calcium signaling cascade links dopamine D1-D2 receptor heteromer to striatal BDNF production and neuronal growth. Proc Natl Acad Sci USA 2009;106:21377-21382.
24.
Lee SP, So CH, Rashid AJ, Varghese G, Cheng R, Lanca AJ, O'Dowd BF, George SR: Dopamine D1 and D2 receptor co-activation generates a novel phospholipase C-mediated calcium signal. J Biol Chem 2004;279:35671-35678.
25.
Perreault ML, Fan T, Alijaniaram M, O'Dowd BF, George SR: Dopamine D1-D2 receptor heteromer in dual phenotype GABA/glutamate-coexpressing striatal medium spiny neurons: regulation of BDNF, GAD67 and VGLUT1/2. PLoS One 2012;7:e33348.
26.
Perreault ML, Hasbi A, Alijaniaram M, Fan T, Varghese G, Fletcher PJ, Seeman P, O'Dowd BF, George SR: The dopamine D1-D2 receptor heteromer localizes in dynorphin/enkephalin neurons: increased high affinity state following amphetamine and in schizophrenia. J Biol Chem 2010;285:36625-36634.
27.
Rashid AJ, So CH, Kong MM, Furtak T, El-Ghundi M, Cheng R, O'Dowd BF, George SR: D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum. Proc Natl Acad Sci USA 2007;104:654-659.
28.
Perreault ML, Hasbi A, Alijaniaram M, O'Dowd BF, George SR: Reduced striatal dopamine D1-D2 receptor heteromer expression and behavioural subsensitivity in juvenile rats. Neuroscience 2012;225:130-139.
29.
Perreault ML, Hasbi A, O'Dowd BF, George SR: The dopamine D1-D2 receptor heteromer in striatal medium spiny neurons: evidence for a third distinct neuronal pathway in basal ganglia. Front Neuroanat 2011;5:31.
30.
Guzman JN, Hernandez A, Galarraga E, Tapia D, Laville A, Vergara R, Aceves J, Bargas J: Dopaminergic modulation of axon collaterals interconnecting spiny neurons of the rat striatum. J Neurosci 2003;23:8931-8940.
31.
Perreault ML, Fan T, O'Dowd BF, George SR: Enhanced brain-derived neurotrophic factor signaling in the nucleus accumbens of juvenile rats. Dev Neurosci 2013;35:384-395.
32.
Ng J, Rashid AJ, So CH, O'Dowd BF, George SR: Activation of calcium/calmodulin-dependent protein kinase IIα in the striatum by the heteromeric D1-D2 dopamine receptor complex. Neuroscience 2010;165:535-541.
33.
Anderson SM, Famous KR, Sadri-Vakili G, Kumaresan V, Schmidt HD, Bass CE, Terwilliger EF, Cha JH, Pierce RC: CaMKII: a biochemical bridge linking accumbens dopamine and glutamate systems in cocaine seeking. Nat Neurosci 2008;11:344-353.
34.
Koo JW, Mazei-Robison MS, Chaudhury D, Juarez B, LaPlant Q, Ferguson D, Feng J, Sun H, Scobie KN, Damez-Werno D, Crumiller M, Ohnishi YN, Ohnishi YH, Mouzon E, Dietz DM, Lobo MK, Neve RL, Russo SJ, Han MH, Nestler EJ: BDNF is a negative modulator of morphine action. Science 2012;338:124-128.
35.
Kourrich S, Klug JR, Mayford M, Thomas MJ: AMPAR-independent effect of striatal αCaMKII promotes the sensitization of cocaine reward. J Neurosci 2012;32:6578-6586.
36.
Liu X, Liu Y, Zhong P, Wilkinson B, Qi J, Olsen CM, Bayer KU, Liu QS: CaMKII activity in the ventral tegmental area gates cocaine-induced synaptic plasticity in the nucleus accumbens. Neuropsychopharmacology 2014;39:989-999.
37.
Zhou Z, Hong EJ, Cohen S, Zhao WN, Ho HY, Schmidt L, Chen WG, Lin Y, Savner E, Griffith EC, Hu L, Steen JA, Weitz CJ, Greenberg ME: Brain-specific phosphorylation of MeCP2 regulates activity-dependent BDNF transcription, dendritic growth, and spine maturation. Neuron 2006;52:255-269.
38.
Song B, Lai B, Zheng Z, Zhang Y, Luo J, Wang C, Chen Y, Woodgett JR, Li M: Inhibitory phosphorylation of GSK-3 by CaMKII couples depolarization to neuronal survival. J Biol Chem 2010;285:41122-41134.
39.
Autry AE, Monteggia LM: Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol Rev 2012;64:238-258.
40.
Wang J, Sun LL, Zhu WL, Sun Y, Liu JF, Lu L, Shi J: Role of calcineurin in the VTA in rats behaviorally sensitized to methamphetamine. Psychopharmacology (Berl) 2012;220:117-128.
41.
Wu P, Xue YX, Ding ZB, Xue LF, Xu CM, Lu L: Glycogen synthase kinase 3β in the basolateral amygdala is critical for the reconsolidation of cocaine reward memory. J Neurochem 2011;118:113-125.
42.
Xu CM, Wang J, Wu P, Xue YX, Zhu WL, Li QQ, Zhai HF, Shi J, Lu L: Glycogen synthase kinase 3β in the nucleus accumbens core is critical for methamphetamine-induced behavioral sensitization. J Neurochem 2011;118:126-139.
43.
Xu CM, Wang J, Wu P, Zhu WL, Li QQ, Xue YX, Zhai HF, Shi J, Lu L: Glycogen synthase kinase 3β in the nucleus accumbens core mediates cocaine-induced behavioral sensitization. J Neurochem 2009;111:1357-1368.
44.
Lisman J, Yasuda R, Raghavachari S: Mechanisms of CaMKII action in long-term potentiation. Nat Rev Neurosci 2012;13:169-182.
45.
Wolf ME: Regulation of AMPA receptor trafficking in the nucleus accumbens by dopamine and cocaine. Neurotox Res 2010;18:393-409.
46.
Bowers MS, Chen BT, Bonci A: AMPA receptor synaptic plasticity induced by psychostimulants: the past, present, and therapeutic future. Neuron 2010;67:11-24.
47.
Ridray S, Griffon N, Mignon V, Souil E, Carboni S, Diaz J, Schwartz JC, Sokoloff P: Coexpression of dopamine D1 and D3 receptors in islands of Calleja and shell of nucleus accumbens of the rat: opposite and synergistic functional interactions. Eur J Neurosci 1998;10:1676-1686.
48.
Perreault ML, Jones-Tabah J, O'Dowd BF, George SR: A physiological role for the dopamine D5 receptor as a regulator of BDNF and Akt signalling in rodent prefrontal cortex. Int J Neuropsychopharmacol 2013;25:1-7.
49.
Coultrap SJ, Bayer KU: CaMKII regulation in information processing and storage. Trends Neurosci 2012;35:607-618.
50.
Hyman SE: Addiction: a disease of learning and memory. Am J Psychiatry 2005;162:1414-1422.
51.
Hyman SE, Malenka RC, Nestler EJ: Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 2006;29:565-598.
52.
Meyer T, Hanson PI, Stryer L, Schulman H: Calmodulin trapping by calcium-calmodulin-dependent protein kinase. Science 1992;256:1199-1202.
53.
Robison AJ, Vialou V, Mazei-Robison M, Feng J, Kourrich S, Collins M, Wee S, Koob G, Turecki G, Neve R, Thomas M, Nestler EJ: Behavioral and structural responses to chronic cocaine require a feed-forward loop involving ΔFosB and calcium/calmodulin-dependent protein kinase II in the nucleus accumbens shell. J Neurosci 2013;33:4295-4307.
54.
Loweth JA, Baker LK, Guptaa T, Guillory AM, Vezina P: Inhibition of CaMKII in the nucleus accumbens shell decreases enhanced amphetamine intake in sensitized rats. Neurosci Lett 2008;444:157-160.
55.
Loweth JA, Li D, Cortright JJ, Wilke G, Jeyifous O, Neve RL, Bayer KU, Vezina P: Persistent reversal of enhanced amphetamine intake by transient CaMKII inhibition. J Neurosci 2013;33:1411-1416.
56.
Loweth JA, Singer BF, Baker LK, Wilke G, Inamine H, Bubula N, Alexander JK, Carlezon WA Jr, Neve RL, Vezina P: Transient overexpression of α-Ca2+/calmodulin-dependent protein kinase II in the nucleus accumbens shell enhances behavioral responding to amphetamine. J Neurosci 2010;30:939-949.
57.
Liu Z, Zhang JJ, Liu XD, Yu LC: Inhibition of CaMKII activity in the nucleus accumbens shell blocks the reinstatement of morphine-seeking behavior in rats. Neurosci Lett 2012;518:167-171.
58.
Liu Z, Liu XD, Zhang JJ, Yu LC: Increases in αCaMKII phosphorylated on Thr286 in the nucleus accumbens shell but not the core during priming-induced reinstatement of morphine-seeking in rats. Neurosci Lett 2012;526:39-44.
59.
Nestler EJ, Barrot M, Self DW: ΔFosB: a sustained molecular switch for addiction. Proc Natl Acad Sci USA 2001;98:11042-11046.
60.
Robison AJ, Nestler EJ: Transcriptional and epigenetic mechanisms of addiction. Nat Rev Neurosci 2011;12:623-637.
61.
Nestler EJ: Review. Transcriptional mechanisms of addiction: role of ΔFosB. Philos Trans R Soc Lond B Biol Sci 2008;363:3245-3255.
62.
Derkach V, Barria A, Soderling TR: Ca2+/calmodulin-kinase II enhances channel conductance of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate type glutamate receptors. Proc Natl Acad Sci USA 1999;96:3269-3274.
63.
Hyman C, Juhasz M, Jackson C, Wright P, Ip NY, Lindsay RM: Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon. J Neurosci 1994;14:335-347.
64.
Mizuno K, Carnahan J, Nawa H: Brain-derived neurotrophic factor promotes differentiation of striatal GABAergic neurons. Dev Biol 1994;165:243-256.
65.
Ventimiglia R, Mather PE, Jones BE, Lindsay RM: The neurotrophins BDNF, NT-3 and NT-4/5 promote survival and morphological and biochemical differentiation of striatal neurons in vitro. Eur J Neurosci 1995;7:213-222.
66.
Kohara K, Yasuda H, Huang Y, Adachi N, Sohya K, Tsumoto T: A local reduction in cortical GABAergic synapses after a loss of endogenous brain-derived neurotrophic factor, as revealed by single-cell gene knock-out method. J Neurosci 2007;27:7234-7244.
67.
Hyman C, Hofer M, Barde YA, Juhasz M, Yancopoulos GD, Squinto SP, Lindsay RM: BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 1991;350:230-232.
68.
Bahi A, Boyer F, Chandrasekar V, Dreyer JL: Role of accumbens BDNF and TrkB in cocaine-induced psychomotor sensitization, conditioned-place preference, and reinstatement in rats. Psychopharmacology (Berl) 2008;199:169-182.
69.
Graham DL, Edwards S, Bachtell RK, DiLeone RJ, Rios M, Self DW: Dynamic BDNF activity in nucleus accumbens with cocaine use increases self-administration and relapse. Nat Neurosci 2007;10:1029-1037.
70.
Graham DL, Krishnan V, Larson EB, Graham A, Edwards S, Bachtell RK, Simmons D, Gent LM, Berton O, Bolanos CA, DiLeone RJ, Parada LF, Nestler EJ, Self DW: Tropomyosin-related kinase B in the mesolimbic dopamine system: region-specific effects on cocaine reward. Biol Psychiatry 2009;65:696-701.
71.
Berglind WJ, See RE, Fuchs RA, Ghee SM, Whitfield TW Jr, Miller SW, McGinty JF: A BDNF infusion into the medial prefrontal cortex suppresses cocaine seeking in rats. Eur J Neurosci 2007;26:757-766.
72.
Berglind WJ, Whitfield TW Jr, LaLumiere RT, Kalivas PW, McGinty JF: A single intra-PFC infusion of BDNF prevents cocaine-induced alterations in extracellular glutamate within the nucleus accumbens. J Neurosci 2009;29:3715-3719.
73.
Whitfield TW Jr, Shi X, Sun WL, McGinty JF: The suppressive effect of an intra-prefrontal cortical infusion of BDNF on cocaine-seeking is Trk receptor and extracellular signal-regulated protein kinase mitogen-activated protein kinase dependent. J Neurosci 2011;31:834-842.
74.
Sadri-Vakili G, Kumaresan V, Schmidt HD, Famous KR, Chawla P, Vassoler FM, Overland RP, Xia E, Bass CE, Terwilliger EF, Pierce RC, Cha JH: Cocaine-induced chromatin remodeling increases brain-derived neurotrophic factor transcription in the rat medial prefrontal cortex, which alters the reinforcing efficacy of cocaine. J Neurosci 2010;30:11735-11744.
75.
Li X, DeJoseph MR, Urban JH, Bahi A, Dreyer JL, Meredith GE, Ford KA, Ferrario CR, Loweth JA, Wolf ME: Different roles of BDNF in nucleus accumbens core versus shell during the incubation of cue-induced cocaine craving and its long-term maintenance. J Neurosci 2013;33:1130-1142.
76.
Pu L, Liu QS, Poo MM: BDNF-dependent synaptic sensitization in midbrain dopamine neurons after cocaine withdrawal. Nat Neurosci 2006;9:605-607.
77.
Wildburger NC, Laezza F: Control of neuronal ion channel function by glycogen synthase kinase 3: new prospective for an old kinase. Front Mol Neurosci 2012;5:80.
78.
Grimes CA, Jope RS: The multifaceted roles of glycogen synthase kinase 3β in cellular signaling. Prog Neurobiol 2001;65:391-426.
79.
Beaulieu JM: A role for Akt and glycogen synthase kinase 3 as integrators of dopamine and serotonin neurotransmission in mental health. J Psychiatry Neurosci 2012;37:7-16.
80.
Freyberg Z, Ferrando SJ, Javitch JA: Roles of the Akt/GSK-3 and Wnt signaling pathways in schizophrenia and antipsychotic drug action. Am J Psychiatry 2010;167:388-396.
81.
Miller JS, Tallarida RJ, Unterwald EM: Cocaine-induced hyperactivity and sensitization are dependent on GSK3. Neuropharmacology 2009;56:1116-1123.
82.
Hernandez F, Lucas JJ, Avila J: GSK3 and tau: two convergence points in Alzheimer's disease. J Alzheimers Dis 2013;33(suppl 1):S141-S144.
83.
Hernandez F, Gomez de Barreda E, Fuster-Matanzo A, Lucas JJ, Avila J: GSK3: a possible link between beta amyloid peptide and tau protein. Exp Neurol 2010;223:322-325.
84.
Sutherland C, Leighton IA, Cohen P: Inactivation of glycogen synthase kinase 3β by phosphorylation: new kinase connections in insulin and growth-factor signalling. Biochem J 1993;296:15-19.
85.
Goode N, Hughes K, Woodgett JR, Parker PJ: Differential regulation of glycogen synthase kinase 3β by protein kinase C isotypes. J Biol Chem 1992;267:16878-16882.
86.
Tsujio I, Tanaka T, Kudo T, Nishikawa T, Shinozaki K, Grundke-Iqbal I, Iqbal K, Takeda M: Inactivation of glycogen synthase kinase 3 by protein kinase Cδ: implications for regulation of tau phosphorylation. FEBS Lett 2000;469:111-117.
87.
Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA: Inhibition of glycogen synthase kinase 3 by insulin mediated by protein kinase B. Nature 1995;378:785-789.
88.
Goel R, Baldassare JJ: β-Arrestin1 couples thrombin to the rapid activation of the Akt pathway. Ann NY Acad Sci 2002;973:138-141.
89.
Povsic TJ, Kohout TA, Lefkowitz RJ: β-Arrestin1 mediates insulin-like growth factor 1 (IGF-1) activation of phosphatidylinositol 3-kinase (PI3K) and anti-apoptosis. J Biol Chem 2003;278:51334-51339.
90.
Li BS, Ma W, Jaffe H, Zheng Y, Takahashi S, Zhang L, Kulkarni AB, Pant HC: Cyclin-dependent kinase 5 is involved in neuregulin-dependent activation of phosphatidylinositol 3-kinase and Akt activity mediating neuronal survival. J Biol Chem 2003;278:35702-35709.
91.
Cross DA, Watt PW, Shaw M, van der Kaay J, Downes CP, Holder JC, Cohen P: Insulin activates protein kinase B, inhibits glycogen synthase kinase 3 and activates glycogen synthase by rapamycin-insensitive pathways in skeletal muscle and adipose tissue. FEBS Lett 1997;406:211-215.
92.
Chen G, Bower KA, Ma C, Fang S, Thiele CJ, Luo J: Glycogen synthase kinase 3β (GSK3β) mediates 6-hydroxydopamine-induced neuronal death. FASEB J 2004;18:1162-1164.
93.
Elliott E, Atlas R, Lange A, Ginzburg I: Brain-derived neurotrophic factor induces a rapid dephosphorylation of tau protein through a PI-3 kinase signalling mechanism. Eur J Neurosci 2005;22:1081-1089.
94.
Beaulieu JM, Sotnikova TD, Marion S, Lefkowitz RJ, Gainetdinov RR, Caron MG: An Akt/β-arrestin2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell 2005;122:261-273.
95.
Beaulieu JM, Sotnikova TD, Yao WD, Kockeritz L, Woodgett JR, Gainetdinov RR, Caron MG: Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proc Natl Acad Sci USA 2004;101:5099-5104.
96.
Sahu A, Tyeryar KR, Vongtau HO, Sibley DR, Undieh AS: D5 dopamine receptors are required for dopaminergic activation of phospholipase C. Mol Pharmacol 2009;75:447-453.
97.
So CH, Verma V, Alijaniaram M, Cheng R, Rashid AJ, O'Dowd BF, George SR: Calcium signaling by dopamine D5 receptor and D5-D2 receptor hetero-oligomers occurs by a mechanism distinct from that for dopamine D1-D2 receptor hetero-oligomers. Mol Pharmacol 2009;75:843-854.
98.
Suto N, Austin JD, Tanabe LM, Kramer MK, Wright DA, Vezina P: Previous exposure to VTA amphetamine enhances cocaine self-administration under a progressive ratio schedule in a D1 dopamine receptor dependent manner. Neuropsychopharmacology 2002;27:970-979.
99.
Vezina P, Lorrain DS, Arnold GM, Austin JD, Suto N: Sensitization of midbrain dopamine neuron reactivity promotes the pursuit of amphetamine. J Neurosci 2002;22:4654-4662.
100.
Mendrek A, Blaha CD, Phillips AG: Pre-exposure of rats to amphetamine sensitizes self-administration of this drug under a progressive ratio schedule. Psychopharmacology (Berl) 1998;135:416-422.
101.
Wei J, Liu W, Yan Z: Regulation of AMPA receptor trafficking and function by glycogen synthase kinase 3. J Biol Chem 2010;285:26369-26376.
102.
Peineau S, Taghibiglou C, Bradley C, Wong TP, Liu L, Lu J, Lo E, Wu D, Saule E, Bouschet T, Matthews P, Isaac JT, Bortolotto ZA, Wang YT, Collingridge GL: LTP inhibits LTD in the hippocampus via regulation of GSK3β. Neuron 2007;53:703-717.
103.
Cohen P, Alessi DR, Cross DA: PDK1, one of the missing links in insulin signal transduction? FEBS Lett 1997;410:3-10.
104.
Man HY, Lin JW, Ju WH, Ahmadian G, Liu L, Becker LE, Sheng M, Wang YT: Regulation of AMPA receptor-mediated synaptic transmission by clathrin-dependent receptor internalization. Neuron 2000;25:649-662.
105.
Chen P, Gu Z, Liu W, Yan Z: Glycogen synthase kinase 3 regulates N-methyl-D-aspartate receptor channel trafficking and function in cortical neurons. Mol Pharmacol 2007;72:40-51.
106.
Ma YY, Guo CY, Yu P, Lee DY, Han JS, Cui CL: The role of NR2B containing NMDA receptor in place preference conditioned with morphine and natural reinforcers in rats. Exp Neurol 2006;200:343-355.
107.
Scheggi S, Mangiavacchi S, Masi F, Gambarana C, Tagliamonte A, De Montis MG: Dizocilpine infusion has a different effect in the development of morphine and cocaine sensitization: behavioral and neurochemical aspects. Neuroscience 2002;109:267-274.
108.
Schumann J, Yaka R: Prolonged withdrawal from repeated noncontingent cocaine exposure increases NMDA receptor expression and ERK activity in the nucleus accumbens. J Neurosci 2009;29:6955-6963.
109.
Ghasemzadeh MB, Mueller C, Vasudevan P: Behavioral sensitization to cocaine is associated with increased glutamate receptor trafficking to the postsynaptic density after extended withdrawal period. Neuroscience 2009;159:414-426.
110.
Brown TE, Lee BR, Mu P, Ferguson D, Dietz D, Ohnishi YN, Lin Y, Suska A, Ishikawa M, Huang YH, Shen H, Kalivas PW, Sorg BA, Zukin RS, Nestler EJ, Dong Y, Schluter OM: A silent synapse-based mechanism for cocaine-induced locomotor sensitization. J Neurosci 2011;31:8163-8174.
111.
Huang YH, Schluter OM, Dong Y: Cocaine-induced homeostatic regulation and dysregulation of nucleus accumbens neurons. Behav Brain Res 2011;216:9-18.
112.
Kerchner GA, Nicoll RA: Silent synapses and the emergence of a postsynaptic mechanism for LTP. Nat Rev Neurosci 2008;9:813-825.
113.
Huang YH, Lin Y, Mu P, Lee BR, Brown TE, Wayman G, Marie H, Liu W, Yan Z, Sorg BA, Schluter OM, Zukin RS, Dong Y: In vivo cocaine experience generates silent synapses. Neuron 2009;63:40-47.
114.
Isaac JT, Nicoll RA, Malenka RC: Evidence for silent synapses: implications for the expression of LTP. Neuron 1995;15:427-434.
115.
Isaac JT, Crair MC, Nicoll RA, Malenka RC: Silent synapses during development of thalamocortical inputs. Neuron 1997;18:269-280.
116.
Liao D, Hessler NA, Malinow R: Activation of postsynaptically silent synapses during pairing-induced LTP in CA1 region of hippocampal slice. Nature 1995;375:400-404.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.